Lawrence N. Shulman, MD

Associate Professor, Department of Medicine, Harvard Medical School

Physician, Adult Oncology, Brigham And Women's Hospital

Contact Info

Lawrence Shulman
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA, 02215
Mailstop: Dana 1608
Phone: 617-632-2277
Fax: 617-632-2260
Email not available

Assistant

Edna Senato
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Phone: 617-632-2277
Edna_Senato@dfci.harvard.edu

DF/HCC Program Affiliation

Breast Cancer
Translational Pharmacology and Early Therapeutic Trials

Research Abstract

Research is centered around new therapeutics for both patients with breast cancer and patients with malignant lymphomas. This includes the use of new agents and combining chemotherapeutic agents with radiation therapy. In addition, research is directed towards the development of new investigational agents as part of the Phase I experimental therapeutics program.

Publications

View All Publications

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Lawrence N. Shulman, MD Associate Professor, Department of Medicine, Harvard Medical School Physician, Adult Oncology, Brigham And Women's Hospital Contact Info Lawrence Shulman Dana-Farber Cancer Institute 450 Brookline Avenue Boston, MA, 02215 Mailstop: Dana 1608 Phone: 617-632-2277 Fax: 617-632-2260 Email not available Assistant Edna Senato Dana-Farber Cancer Institute 44 Binney Street Boston, MA, 02115 Phone: 617-632-2277 Edna_Senato@dfci.harvard.edu DF/HCC Program Affiliation Breast Cancer Translational Pharmacology and Early Therapeutic Trials Research Abstract Research is centered around new therapeutics for both patients with breast cancer and patients with malignant lymphomas. This includes the use of new agents and combining chemotherapeutic agents with radiation therapy. In addition, research is directed towards the development of new investigational agents as part of the Phase I experimental therapeutics program. Publications View All Publications
Site Map Site Feedback Web Privacy Policy